Owing to its association with inflammation and atherosclerotic risk, Lp‐PLA2 action within adipocytes may represent a potential therapeutic target to prevent the development of cardiometabolic complications in type 2 diabetes.41 On the basis of this study, the perivascular adipose tissue (PVAT), which surrounds most large blood vessels, is probably a potential source of Lp‐PLA2 as well. The gene discussed is PLA2G7; the disease is type 2 diabetes mellitus.